Figure 5.

Levels of CEACAM1 mRNA in pretreatment whole-blood samples from KD patients who subsequently responded (R) or failed to respond (NR) to IVIG treatment. Transcript levels were measured by quantitative RT-PCR, and normalized to TAF1B transcript levels. Black triangles, assay for both long (L) and short (S) splice forms of CEACAM1; gray triangles, L-form; open triangles: S-form. Horizontal bars indicate median relative expression level.